Immatics Management
Management criteria checks 2/4
Immatics' CEO is Harpreet Singh, appointed in Jul 2019, has a tenure of 4.75 years. total yearly compensation is €6.38M, comprised of 7.7% salary and 92.3% bonuses, including company stock and options. directly owns 1.24% of the company’s shares, worth $13.31M. The average tenure of the management team and the board of directors is 3.8 years and 2.9 years respectively.
Key information
Harpreet Singh
Chief executive officer
€6.4m
Total compensation
| CEO salary percentage | 7.7% |
| CEO tenure | 4.8yrs |
| CEO ownership | 1.2% |
| Management average tenure | 3.8yrs |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely
Sep 26
We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely
Jun 12Immatics launches $110M stock offering
Oct 10Cancer immunotherapy biotech Immatics up 18% on 4x normal volume
Jul 19Here's Why We're Watching Immatics' (NASDAQ:IMTX) Cash Burn Situation
Jan 29Analysts' Revenue Estimates For Immatics N.V. (NASDAQ:IMTX) Are Surging Higher
Dec 16Immatics N.V. (NASDAQ:IMTX) Analysts Are Pretty Bullish On The Stock After Recent Results
Apr 01What Is The Ownership Structure Like For Immatics N.V. (NASDAQ:IMTX)?
Jan 18Immatics reports Q3 results
Dec 02Immatics (IMTX) Investor Presentation - Slideshow
Nov 13CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | €6m | €488k | -€97m |
| Sep 30 2023 | n/a | n/a | -€84m |
| Jun 30 2023 | n/a | n/a | -€79m |
| Mar 31 2023 | n/a | n/a | -€68m |
| Dec 31 2022 | €7m | €522k | €38m |
Compensation vs Market: Harpreet's total compensation ($USD6.83M) is above average for companies of similar size in the US market ($USD3.43M).
Compensation vs Earnings: Harpreet's compensation has been consistent with company performance over the past year.
CEO
Harpreet Singh (48 yo)
4.8yrs
Tenure
€6,378,000
Compensation
Dr. Harpreet Singh, Ph D., has been Non-Executive Director of Immatics N.V. since July 1, 2021 and served as its Supervisory Director since 2021 until July 1, 2021. Dr. Singh serves as Chief Executive Offi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD | 4.8yrs | €6.38m | 1.24% € 13.3m | |
| Co-Founder & Chief Innovation Officer | 24.3yrs | no data | 0.31% € 3.4m | |
| Chief Financial Officer | 3.5yrs | no data | 0.16% € 1.8m | |
| Chief Operations Officer | 1.1yrs | no data | 0.27% € 2.9m | |
| General Counsel & Secretary | 3.8yrs | no data | 0.10% € 1.1m | |
| Chief Development Officer | 4.5yrs | no data | 0.45% € 4.8m | |
| Chief Medical Officer | 3.8yrs | no data | 0.22% € 2.4m | |
| Head of Strategy | no data | no data | 0.19% € 2.0m | |
| Co-Founder & Member of the Scientific Advisory Board | 24.3yrs | no data | no data | |
| Vice President of SEC Reporting & Accounting | less than a year | no data | no data | |
| VP of Administration & Operations and US Site Head | no data | no data | no data | |
| Chief Business Officer & Site Head Munich | no data | no data | 0.31% € 3.3m |
3.8yrs
Average Tenure
48yo
Average Age
Experienced Management: IMTX's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD | 2.8yrs | €6.38m | 1.24% € 13.3m | |
| Co-Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Non-Executive Director | 2.8yrs | €263.00k | 0.054% € 576.4k | |
| Non-Executive Chairman | 2.8yrs | €283.00k | 0.36% € 3.9m | |
| Independent Vice Chair of the Board of Directors | 2.8yrs | €246.00k | 0.054% € 576.4k | |
| Member of Scientific Advisory Board | 3.8yrs | no data | no data | |
| Co-Chair of the Scientific Advisory Board | 3.1yrs | no data | no data | |
| Independent Non-Executive Director | 2.8yrs | €259.00k | 0.054% € 576.4k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Co-Chair of the Scientific Advisory Board | 3.6yrs | no data | no data | |
| Member of Scientific Advisory Board | 3.8yrs | no data | no data |
2.9yrs
Average Tenure
62yo
Average Age
Experienced Board: IMTX's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.